
Vanguard Biomedical Corp.
Free shipping on orders over $99 · 30-day returns
MINICLINIC OVULATION PREDICTION TEST is an FDA 510(k)-cleared medical device (K910351) manufactured by Vanguard Biomedical Corp.. This device is classified under the Clinical Chemistry specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on March 20, 1991. Regulation: 8.